Predictors of response to intra-articular steroid injection in psoriatic arthritis

Rheumatology

Volumn 49, Issue 7, 2010, Pages 1367-1373

  Eder, Lihi ^a   Chandran, Vinod ^a   Ueng, Joanna ^a   Bhella, Sita ^a   Lee, Ker Ai ^b   Rahman, Proton ^c   Pope, Angela ^c   Cook, Richard J ^b   Gladman, Dafna D ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Corticosteroids; Gene polymorphism; Intra articular injections; Macrophage migration inhibition factor; Psoriatic arthritis

Indexed keywords

CORTICOSTEROID; MACROPHAGE MIGRATION INHIBITION FACTOR; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; COHORT ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PSORIATIC ARTHRITIS; RELAPSE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADRENAL CORTEX HORMONES; ADULT; ARTHRALGIA; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954212051     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq102     Document Type: Article

References (26)

1. Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 2003;88:192-6.
2. Wallen M, Gillies D. Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database Syst Rev 2006;1: CD002824.
3. Chandler GN, Wright V, Hartfall SJ. Intra-articular therapy in rheumatoid arthritis: comparison of hydrocortisone tertiary butyl acetate and hydrocortisone acetate. Lancet 1958;2:659-61.
4. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999;83:525-32.
5. van Vliet-Daskalopoulou E, Jentjens T, Scheffer RTC. Intra-articular rimexolone in the rheumatoid knee: a placebo-controlled, double-blind, multicentre trial of three doses. Br J Rheumatol 1987;26:450-3.
6. Ayoub S, Hickey MJ, Morand EF. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol 2008;4:98-105.
7. Aeberli D, Leech M, Morand EF. Macrophage migration inhibitory factor and glucocorticoid sensitivity. Rheumatology 2006;45:937-43.
8. Kim HR, Park MK, Cho ML et al. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol 2007;34:927-36.
9. Radstake TR, Sweep FC, Welsing P et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005;52:3020-9.
10. Baugh JA, Chitnis S, Donnelly SC et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3: 170-6.
11. Vivarelli M, D'Urbano LE, Insalaco A et al. Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. Clin Exp Rheumatol 2007;25:775-81.
12. Radstake TR, Fransen J, Toonen EJ et al. Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis. Ann Rheum Dis 2007;66:1525-30.
13. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PsA)-an analysis of 220 patients. Q J Med 1987;62:127-41.
14. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D. Radiological assessment in psoriatic arthritis. Br J Rheumatol 1998;37:760-5.
15. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42: 121-30.
16. Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998;41:1210-4.
17. Allen RC, Gross KR, Laxer RM, Malleson PN, Beauchamp RD, Petty RE. Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum 1986;29:997-1001.
18. Hauzeur JP, Mathy L, De Maertelaer V. Comparison between clinical evaluation and ultrasonography in detecting hydrarthrosis of the knee. J Rheumatol 1999;26:2681-3.
19. Karim Z, Wakefield RJ, Quinn M et al. Validation and reproducibility of ultrasonography in the detection of synovitis in the knee: a comparison with arthroscopy and clinical examination. Arthritis Rheum 2004;50:387-94.
20. Giles JT, Mease P, Boers M, Bresnihan B. Assessing single joints in arthritis clinical trials. J Rheumatol 2007;34: 641-7.
21. Gladman DD, Cook RJ, Schentag C et al. The clinical assessment of patients with psoriatic arthritis: results of a validation study of the spondyloarthritis research consortium of Canada (SPARCC). J Rheumatol 2004;31: 1126-31.
22. Gladman DD, Inman RD, Cook RJ et al. International spondyloarthritis interobserver reliability exercise - the INSPIRE study: II. Assessment of peripheral joint, enthesitis and dactylitis. J Rheumatol 2007;34:1740-5.
23. Marti P, Molinari L, Bolt IB, Seger R, Saurenmann RK. Factors influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis. Eur J Pediatr 2008;167:425-30.
24. Berdeli A, Ozyürek AR, Ulger Z et al. Association of macrophage migration inhibitory factor gene -173G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int 2006;26:726-31.
25. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007;80:531-8.
26. Rahman P, Snelgrove T, Peddle L et al. A variant of the IL4 I50V single-nucleotide polymorphism is associated with erosive joint disease in psoriatic arthritis. Arthritis Rheum 2008;58:2207-8.